The novel therapy of tirzepatide peptide represents a significant development in the management of the condition. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide104334.wizzardsblog.com/41999925/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment